CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 1 of 2
Non-Antibody Products
Page 1,721 of 2,593
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| NS 11394 | A positive allosteric modulator of the GABAA receptor (Ki = 0.423 nM); sel… | 5 mg | 23872-5 | More Info |
| NS 13001 | A positive allosteric modulator of KCa2.2 / SK2 and KCa2.3 / SK3; increase… | 1 mg | 37317-1 | More Info |
| NS 13001 | A positive allosteric modulator of KCa2.2 / SK2 and KCa2.3 / SK3; increase… | 10 mg | 37317-10 | More Info |
| NS 13001 | A positive allosteric modulator of KCa2.2 / SK2 and KCa2.3 / SK3; increase… | 25 mg | 37317-25 | More Info |
| NS 13001 | A positive allosteric modulator of KCa2.2 / SK2 and KCa2.3 / SK3; increase… | 5 mg | 37317-5 | More Info |
| NS 1619 | A calcium-dependent activator of BKCa channels that is typically used at a… | 1 mg | 18876-1 | More Info |
| NS 1619 | A calcium-dependent activator of BKCa channels that is typically used at a… | 10 mg | 18876-10 | More Info |
| NS 1619 | A calcium-dependent activator of BKCa channels that is typically used at a… | 25 mg | 18876-25 | More Info |
| NS 1619 | A calcium-dependent activator of BKCa channels that is typically used at a… | 5 mg | 18876-5 | More Info |
| NS 1643 | An activator of ERG1 (KV11.1, KCNH2, hERG; EC50 = 10.5 µM); also act… | 10 mg | 20343-10 | More Info |
| NS 1643 | An activator of ERG1 (KV11.1, KCNH2, hERG; EC50 = 10.5 µM); also act… | 25 mg | 20343-25 | More Info |
| NS 1643 | An activator of ERG1 (KV11.1, KCNH2, hERG; EC50 = 10.5 µM); also act… | 5 mg | 20343-5 | More Info |
| NS 1643 | An activator of ERG1 (KV11.1, KCNH2, hERG; EC50 = 10.5 µM); also act… | 50 mg | 20343-50 | More Info |
| NS 1738 | A positive allosteric modulator of the α7-containing nAChRs, increas… | 1 mg | 21018-1 | More Info |
| NS 1738 | A positive allosteric modulator of the α7-containing nAChRs, increas… | 10 mg | 21018-10 | More Info |
| NS 1738 | A positive allosteric modulator of the α7-containing nAChRs, increas… | 5 mg | 21018-5 | More Info |
| NS 2028 | NS 2028 is a specific inhibitor of soluble guanylyl cyclase. It inhibits p… | 1 mg | 81600-1 | More Info |
| NS 2028 | NS 2028 is a specific inhibitor of soluble guanylyl cyclase. It inhibits p… | 10 mg | 81600-10 | More Info |
| NS 2028 | NS 2028 is a specific inhibitor of soluble guanylyl cyclase. It inhibits p… | 25 mg | 81600-25 | More Info |
| NS 2028 | NS 2028 is a specific inhibitor of soluble guanylyl cyclase. It inhibits p… | 5 mg | 81600-5 | More Info |
| NS 304 | An IP receptor agonist prodrug; a long-lasting prodrug of the active form… | 1 mg | 10010411-1 | More Info |
| NS 304 | An IP receptor agonist prodrug; a long-lasting prodrug of the active form… | 10 mg | 10010411-10 | More Info |
| NS 304 | An IP receptor agonist prodrug; a long-lasting prodrug of the active form… | 5 mg | 10010411-5 | More Info |
| NS 304 | An IP receptor agonist prodrug; a long-lasting prodrug of the active form… | 50 mg | 10010411-50 | More Info |
| NS 309 | A nonselective activator of SK / KCa2 and IK / KCa3.1 channels (EC50s rang… | 10 mg | 18889-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile